Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
2001 2
2003 1
2004 2
2005 1
2007 2
2008 2
2009 2
2010 1
2011 2
2012 1
2013 1
2015 3
2016 3
2017 1
2018 1
2019 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

25 results
Results by year
Filters applied: . Clear all
Page 1
Cardiovascular risk reduction with once-weekly semaglutide in subjects with type 2 diabetes: a post hoc analysis of gender, age, and baseline CV risk profile in the SUSTAIN 6 trial.
Leiter LA, Bain SC, Hramiak I, Jódar E, Madsbad S, Gondolf T, Hansen T, Holst I, Lingvay I. Leiter LA, et al. Cardiovasc Diabetol. 2019 Jun 6;18(1):73. doi: 10.1186/s12933-019-0871-8. Cardiovasc Diabetol. 2019. PMID: 31167654 Free PMC article.
BACKGROUND: The SUSTAIN 6 trial demonstrated that once-weekly semaglutide (0.5 and 1.0 mg) significantly reduced major adverse cardiovascular (CV) events (MACE) vs placebo in subjects with type 2 diabetes (T2D) and high CV risk. The effects of gender, age and baseline CV r …
BACKGROUND: The SUSTAIN 6 trial demonstrated that once-weekly semaglutide (0.5 and 1.0 mg) significantly reduced major adverse cardiovascula …
Association of a Combined Measure of Adherence and Treatment Intensity With Cardiovascular Outcomes in Patients With Atherosclerosis or Other Cardiovascular Risk Factors Treated With Statins and/or Ezetimibe.
Khunti K, Danese MD, Kutikova L, Catterick D, Sorio-Vilela F, Gleeson M, Kondapally Seshasai SR, Brownrigg J, Ray KK. Khunti K, et al. JAMA Netw Open. 2018 Dec 7;1(8):e185554. doi: 10.1001/jamanetworkopen.2018.5554. JAMA Netw Open. 2018. PMID: 30646277 Free PMC article.
OBJECTIVE: To evaluate the association of adherence and treatment intensity with cardiovascular outcomes in patients with documented cardiovascular disease (CVD), type 2 diabetes without CVD or chronic kidney disease (CKD), and CKD without CVD. ...MAIN OUTCOMES AND …
OBJECTIVE: To evaluate the association of adherence and treatment intensity with cardiovascular outcomes in patients with documented cardiov …
Influence of revascularization on long-term outcome in patients > or =75 years of age with diabetes mellitus and angina pectoris.
Jeger RV, Bonetti PO, Zellweger MJ, Tobler D, Kaiser CA, Osswald S, Buser PT, Pfisterer ME. Jeger RV, et al. Am J Cardiol. 2005 Jul 15;96(2):193-8. doi: 10.1016/j.amjcard.2005.03.042. Am J Cardiol. 2005. PMID: 16018840 Clinical Trial.
Little is known about the effect of revascularization in patients > or =75 years of age with symptomatic coronary artery disease (CAD) and diabetes mellitus (DM) for whom periprocedural risk and overall mortality are increased. ...In conclusion, elderly diabetic …
Little is known about the effect of revascularization in patients > or =75 years of age with symptomatic coronary artery disease (CAD) an …
Utility of ranolazine in chronic stable angina patients.
Patel PD, Arora RR. Patel PD, et al. Vasc Health Risk Manag. 2008;4(4):819-24. doi: 10.2147/vhrm.s2841. Vasc Health Risk Manag. 2008. PMID: 19065998 Free PMC article. Review.
Chronic stable angina is a debilitating illness affecting at least 6.6 million US residents. Despite being optimally treated by pharmacotherapy and revascularization up to 26% of patients still experience angina. Diabetes mellitus is a common co …
Chronic stable angina is a debilitating illness affecting at least 6.6 million US residents. Despite being optimally treated b …
Management of chronic stable angina pectoris.
Rodríguez-Ospina L, Montano-Soto L. Rodríguez-Ospina L, et al. Bol Asoc Med P R. 2008 Oct-Dec;100(4):39-47. Bol Asoc Med P R. 2008. PMID: 19400528 Review.
It is most commonly caused by the inability of narrowed atherosclerotic coronary arteries to supply adequate oxygen to the heart under conditions of increase demand. This review article will focus in the medical treatment of chronic stable angina, with a focus in ne …
It is most commonly caused by the inability of narrowed atherosclerotic coronary arteries to supply adequate oxygen to the heart under condi …
Progress in HDL-based therapies for atherosclerosis.
Chyu KY, Peter A, Shah PK. Chyu KY, et al. Curr Atheroscler Rep. 2011 Oct;13(5):405-12. doi: 10.1007/s11883-011-0189-9. Curr Atheroscler Rep. 2011. PMID: 21744164 Review.
Atherosclerosis is a chronic inflammatory disease affecting medium and large arteries resulting from a complex interaction between genetic and environmental risk factors that include dyslipidemia, hypertension, diabetes mellitus, and smoking. ...However, a la …
Atherosclerosis is a chronic inflammatory disease affecting medium and large arteries resulting from a complex interaction between ge …
[Myocardial infarct and unstable angina pectoris: diagnostics and therapy].
Weber M, Hamm C. Weber M, et al. Internist (Berl). 2007 Apr;48(4):399-410; quiz 411-2. doi: 10.1007/s00108-007-1802-4. Internist (Berl). 2007. PMID: 17333052 Review. German.
Acute coronary syndromes include ST-elevation and non-ST elevation myocardial infarction, and unstable angina pectoris. These are characterised by the acute onset of chest pain. ...For patients with an acute coronary syndrome without ST-elevation, a risk adapted …
Acute coronary syndromes include ST-elevation and non-ST elevation myocardial infarction, and unstable angina pectoris. These …
Optimal therapeutic strategy for treating patients with hypertension and atherosclerosis: focus on olmesartan medoxomil.
Mason RP. Mason RP. Vasc Health Risk Manag. 2011;7:405-16. doi: 10.2147/VHRM.S20737. Epub 2011 Jun 24. Vasc Health Risk Manag. 2011. PMID: 21796255 Free PMC article. Review.
Atherogenesis is initiated by endothelial injury due to oxidative stress associated with CV risk factors including diabetes mellitus, hypertension, cigarette smoking, dyslipidemia, obesity, and metabolic syndrome. ...Several prospective, randomized studies show vasc …
Atherogenesis is initiated by endothelial injury due to oxidative stress associated with CV risk factors including diabetes mellit …
Updates and current recommendations for the management of patients with non-ST-elevation acute coronary syndromes: what it means for clinical practice.
Cayla G, Silvain J, Collet JP, Montalescot G. Cayla G, et al. Am J Cardiol. 2015 Mar 14;115(5 Suppl):10A-22A. doi: 10.1016/j.amjcard.2015.01.003. Epub 2015 Jan 7. Am J Cardiol. 2015. PMID: 25728969 Review.
The American Heart Association (AHA) and the American College of Cardiology (ACC) have recently updated their joint guidelines for the management of patients with non-ST-elevation acute coronary syndromes (NSTE-ACS, including unstable angina [UA] and non-ST-elevation myoca …
The American Heart Association (AHA) and the American College of Cardiology (ACC) have recently updated their joint guidelines for the manag …
The Usefulness of Spinal Cord Stimulation for Chronic Pain Due to Combined Vasospastic Prinzmetal Angina and Diabetic Neuropathic Pain of the Lower Limbs.
Kinfe TM, Pintea B. Kinfe TM, et al. J Neurol Surg A Cent Eur Neurosurg. 2016 Mar;77(2):176-8. doi: 10.1055/s-0034-1543960. Epub 2015 Aug 3. J Neurol Surg A Cent Eur Neurosurg. 2016. PMID: 26238940
BACKGROUND: To the best of our knowledge, the use of spinal cord stimulation (SCS) utilizing a single lead as a treatment strategy for combined Prinzmetal angina, a cardiac ischemia-induced disturbance of nociceptive perception, and diabetic neuropathy of the lower …
BACKGROUND: To the best of our knowledge, the use of spinal cord stimulation (SCS) utilizing a single lead as a treatment strategy fo …
25 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page